In the latest trading session,, 0.5 million Denali Therapeutics Inc (NASDAQ:DNLI) shares changed hands as the company’s beta touched 1.33. With the company’s most recent
Denali Therapeutics Inc (NASDAQ:DNLI) has a beta value of 1.32 and has seen 0.9 million shares traded in the recent trading session. The company, currently
Denali Therapeutics Inc (NASDAQ:DNLI)’s traded shares stood at 0.79 million during the last session, with the company’s beta value hitting 1.36. At the close of
In the last trading session, 1.01 million Denali Therapeutics Inc (NASDAQ:DNLI) shares changed hands as the company’s beta touched 1.31. With the company’s per share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne